TABLE 2

Patient Characteristics

Administered dose (MBq)
PatientAge (y)SexHeart failureNYHA functional classLVEF (%)123I-MIBG99mTc-tetrofosminHMRplanarHMRreprojHMRtransaxialcHMRreprojcHMRtransaxial
170MICMII361962411.541.231.481.61.51
267MICMIII201812221.411.121.361.551.46
365FNICMII301512641.230.830.881.411.26
477MNICMI441253701.380.961.21.481.4
582MNICMI441812651.351.040.991.511.31
667MICMII322062821.370.851.181.421.38
779MICMI342122451.531.381.421.681.48
875MICMII331991091.411.211.171.591.38
973MICMII452046321.481.021.471.51.51
1078MICMI441862711.391.091.521.541.53
1167MNICMII401547341.541.131.61.561.56
1281MNICMII401832761.361.01.51.491.52
1369FNICMI401925781.481.121.471.551.51
1485MICMI402122251.561.11.681.541.59
1578MICMI452001761.00.480.221.240.99
1664MNICMIII201892321.571.281.781.631.63
1776MICMI361895251.631.181.731.581.61
1858MNICMIII241253701.361.061.021.521.32
1970MNICMII351198801.631.61.841.791.66
2059MICMI352212901.351,001.021.491.32
2160MICMII311935491.320.980.971.481.3
2282MNICMII321755281.651.171.891.581.68
2355MNICMII352042631.531.261.521.621.52
2470MICMII351962881.280.921.231.451.41
2577MNICMIII291912251.481.031.381.511.47
2680MICMII302232671.351.061.041.521.33
2768MICMII351522631.371.111.361.551.46
2880MICMII301883021.321.21.261.591.42
2967MNICMII331993351.481.221.371.61.47
3071MICMII352163081.310.991.111.491.36
3170MICMII402142751.261.191.11.581.35
3270FNICMII331975971.421.091.391.531.47
3372FICMI332222351.641.081.741.531.62
3454MICMII301813171.441.331.241.651.41
3559FNICMI422063261.280.911.021.451.32
3660FNICMI452053771.571.11.691.541.6
3772MNICMIII202472951.451.21.111.591.36
3877MNICMII322253451.471.061.291.521.43
3959MICMII401742941.691.481.951.731.7
4059MICMI401987201.571.381.671.681.59
Mean ± SD71 ± 935 ± 9191 ± 41358 ± 1771.44 ± 0.141.12 ± 0.191.35 ± 0.341.54 ± 0.091.45 ± 0.14
  • NYHA = New York Heart Association; ICM = ischemic; NICM = nonischemic.